¿Qué trae la nueva clasificación de las neumonías intersticiales idiopáticas?

What does the new classification of Idiopathic Interstitial Pneumonias bring?

Publicado 2016-12-04

Abrir | Descargar
PDF FLIP
Número
Vol. 25 Núm. 2 (2013)
Sección
Editorial
Cómo citar
¿Qué trae la nueva clasificación de las neumonías intersticiales idiopáticas?.
rev. colomb. neumol. [Internet]. 2016 Dec. 4 [cited 2024 Nov. 21];25(2). Disponible en: https://doi.org/10.30789/rcneumologia.v25.n2.2013.114
DOI

https://doi.org/10.30789/rcneumologia.v25.n2.2013.114
Dimensions
PlumX
Licencia

Ninguna publicación, nacional o extranjera, podrá reproducir ni traducir sus artículos ni sus resúmenes sin previa autorización escrita del editor; sin embargo  los usuarios pueden descargar la información contenida en ella, pero deben darle atribución o reconocimiento de propiedad intelectual, deben usarlo tal como está, sin derivación alguna.

Jorge Pulido Arenas, MD.
Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.
    Mostrar biografía de los autores

    Jorge Pulido Arenas, MD.,

    Internista. Departamento de Medicina Interna. Hospital Universitario San Ignacio. Pontificia Universidad Javeriana. Bogotá, Colombia.

    Visitas del artículo 271 | Visitas PDF 1476

    Descargas

    Los datos de descarga todavía no están disponibles.
    1. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Resp Crit Care Med. 2002;165:277-304.
    2. Hobbs S, Lynch D. The idiopathic interstitial pneumonias: an update and review. Radiol Clin N Am. 2014;52:105-20.
    3. Travis WD, Costabel U, Hansell DM, King TE Jr, et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Resp Crit Care Med. 2013;188:733-48.
    4. Flaherty KR, Andrei AC, King TE Jr, et al. Idiopatic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med. 2007;175:1054-60.
    5. Flaherty KR, King TE Jr, Raghu G, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170;904-10.
    6. Selman M. Hypersensitivity pneumonitis: a multifaceted deceiving disorder. Clin Chest Med. 2004;25:531-47.
    7. Hanak V, Golbin JM, Ryu JH. Causes and presenting features in 85 consecutive patients with hypersensitivity pneumonitis. Mayo Clin Proc. 2007;82:812-16.
    8. van Moorsel CH, van Oosterhout MF, Barlo NP, de Jong PA, van der Vis JJ, Ruven HJ, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med. 2010;182:1419-25.
    9. Lawson WE, Loyd JE, Degryse AL. Genetics in pulmonary fibrosisfamilial cases provide clues to the pathogenesis of idiopathic pulmonary fibrosis. Am J Med Sci. 2011;134:439-3.
    10. Travis WD, Hunninghake G, King TE Jr, Lynch DA, Colby TV, Galvin JR, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society Project. Am J Respir Crit Care Med. 2008;177:1338-47.
    11. Akira M, Inoue Y, Arai T, Okuma T, KAwata Y. Long-term follow-up high-resolution CT findings in non-specific interstitial pneumonia. Thorax. 2011;66:61-5.
    12. Park IN, Jegal Y, Kim DS, Do KH, Yoo B, Shim TS, et al. Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia. Eur Respir J. 2009;33:68-76.
    13. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, et al. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JPS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183:788-824.
    14. Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am J Respir Crit Care Med. 2008;177:433-9.
    15. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, Brown KK, et al. Idiopathic Pulmonary Fibrosis Study Group. High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. Am J Respir Crit Care Med. 2005;172:488-93.
    16. Fraig M, Shreesha U, Savici D, et al. Respiratory bronchiolitis: a clinicopathologic study in current smokers, ex-smokers, and never-smokers. Am J Surg Pathol. 2002;26:647-53.
    17. Vasallo R, Ryu JH. Tobacco smoke-related diffuse lung diseases. Semin Respir Crit Care. 2008;29:643-50.
    18. Portnoy J, Veraldi KL, Schwartz MI, Cool CD, Currant-Everett D, Cherniack RM, et al. Respiratory bronchiolitis-interstitial lung disease: longterm outcome. Chest. 2007;131:664-71.
    19. Doan ML, Guillerman RP, Dishop MK, Nogee LM, Langston C, Mallory GB, et al. Clinical, radiological and pathological features of ABCA3 mutations in children. Thorax. 2008;63:366-73.
    20. Collard HR, Moore BB, Flaherty KR, Brown KK, Kaner RJ, King TE Jr, , et al. Idiopathic Pulmonary Fibrosis Clinical Research Network Investigators. Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care. Med 2007;176:636-43.
    21. Ryerson CJ, Urbania TH, Richeldi L, et al. Prevalence and prognosis of unclassifiable interstitial lung disease. Eur Respir J. 2013;42:750-7.
    22. Barlo NP, van Moorsel CHM, Ruven HJT, Zanen P, van der Bosch JMM, Grutters JC. Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis. 2009;26:155-161.
    23. Kinder BW, Brown KK, McCormack FX, Ix JH, Kervitsky JA, Schwartz MI, et al. Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosis. Chest. 2009;135:1557-63.
    24. Satoh H, Kurishima K, Ishikawa H, Ohtsuka M. increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases. J Intern Med. 2006;260:429-34.
    25. Prasse A, Probst C, Bargagli E, Zissel G, Toews GB, Flaherty KR, et al. Serum CC-chemokine ligand 18 concentrations predicts outcome in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179:717-23.

    Información

    Historia de la revista

    Palabras clave

    Código QR

    Patrocinadores

     Nos apoyan +Info Aquí 

     

    Directorios e indexadores

     

    Perfil de Google Scholar

    Más leídos en los últimos 30 días

    Número actual

    Sistema OJS 3.4.0.7 - Metabiblioteca |